All Title Author
Keywords Abstract

Boesenbergia pandurata Attenuates Diet-Induced Obesity by Activating AMP-Activated Protein Kinase and Regulating Lipid Metabolism

DOI: 10.3390/ijms13010994

Keywords: Boesenbergia pandurata (Roxb.) Schltr., obesity, fatty liver, lipid accumulation, AMP-activated protein kinase

Full-Text   Cite this paper   Add to My Lib


Obesity, a chronic metabolic disorder, is characterized by enlarged fat mass and dysregulation of lipid metabolism. The medicinal plant, Boesenbergia pandurata (Roxb.) Schltr., has been reported to possess anti-oxidative and anti-inflammatory properties; however, its anti-obesity activity is unexplored. The present study was conducted to determine whether B. pandurata extract (BPE), prepared from its rhizome parts, attenuated high-fat diet (HFD)-induced obesity in C57BL/6J mice. The molecular mechanism was investigated in 3T3-L1 adipocytes and HepG2 human hepatoma cells. BPE treatment decreased triglyceride accumulation in both 3T3-L1 adipocytes and HepG2 hepatocytes by activating AMP-activated protein kinase (AMPK) signaling and regulating the expression of lipid metabolism-related proteins. In the animal model, oral administration of BPE (200?mg/kg/day for 8 weeks) significantly reduced HFD-induced body weight gain without altering the amount of food intake. In addition, elevated serum levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides were suppressed by BPE administration. Fat pad masses were reduced in BPE-treated mice, as evidenced by reduced adipocyte size. Furthermore, BPE protected against the development of nonalcoholic fatty liver by decreasing hepatic triglyceride accumulation. BPE also activated AMPK signaling and altered the expression of lipid metabolism-related proteins in white adipose tissue and liver. Taken together, these findings indicate that BPE attenuates HFD-induced obesity by activating AMPK and regulating lipid metabolism, suggesting a potent anti-obesity agent.


[1]  Després, J.P.; Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 2006, 444, 881–887.
[2]  James, P.T.; Rigby, N.; Leach, R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil 2004, 11, 3–8.
[3]  Fujioka, K. Management of obesity as a chronic disease: Nonpharmacologic, pharmacologic, and surgical options. Obes. Res 2002, 10, S116–S123.
[4]  Semenkovich, C.F. Insulin resistance and atherosclerosis. J. Clin. Invest 2006, 116, 1813–1822.
[5]  Shi, Y.; Burn, P. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. Nat. Rev. Drug. Discov 2004, 3, 695–710.
[6]  Savage, D.B.; Petersen, K.F.; Shulman, GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev 2007, 87, 507–520.
[7]  Olefsky, J.M. Fat talks, liver and muscle listen. Cell 2008, 134, 914–916.
[8]  Harvatine, K.J.; Bauman, D.E. SREBP1 and thyroid hormone responsive spot 14 (S14) are involved in the regulation of bovine mammary lipid synthesis during diet-induced milk fat depression and treatment with CLA. J. Nutr 2006, 136, 2468–2474.
[9]  Boden, G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr. Diab. Rep 2006, 6, 177–181.
[10]  Chen, N.; Bezzina, R.; Hinch, E. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res 2009, 29, 784–793.
[11]  Choi, H.; Eo, H.; Park, K. A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model. Biochem. Biophys. Res. Commun 2007, 359, 419–425.
[12]  Hardie, D.G. AMPK: A key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 2008, 32, S7–S12.
[13]  Ouadda, A.B.; Levy, E.; Ziv, E. Increased hepatic lipogenesis in insulin resistance and type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus. Biosci. Rep 2009, 29, 283–292.
[14]  Osler, M.E.; Zierath, J.R. Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 2008, 149, 935–941.
[15]  Hasani-Ranjbar, S.; Nayebi, N.; Larijani, B.; Abdollahi, M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol 2009, 15, 3073–3085.
[16]  Lagouge, M.; Argmann, C.; Gerhart-Hines, Z. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109–1122.
[17]  Lee, M.S.; Kim, C.T.; Kim, Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann. Nutr. Metab 2009, 54, 151–157.
[18]  Kim, W.S.; Lee, Y.S.; Cha, S.H. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am. J. Physiol. Endocrinol. Metab 2009, 296, E812–E819.
[19]  Yun, J.M.; Kwon, H.; Hwang, J.K. In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Med 2003, 69, 1102–1108.
[20]  Shindo, K.; Kato, M.; Kinoshita, A.; Kobayashi, A.; Koike, Y. Analysis of antioxidant activities contained in the Boesenbergia pandurata Schult. Rhizome. Biosci. Biotechnol. Biochem 2006, 70, 2281–2284.
[21]  Lee, Y.S.; Kim, W.S.; Kim, K.H. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55, 2256–2264.
[22]  Kim, D.Y.; Lee, M.S.; Jo, K.; Lee, K.-E. Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment of obesity. Diabetes. Obes. Metab 2011, 13, 584–593.
[23]  Wellen, K.E.; Hotamisligil, G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest 2003, 112, 1785–1788.
[24]  Amini, Z.; Boyd, B.; Doucet, J.; Ribnicky, D.M.; Stephens, J.M. St. John’s Wort inhibits adipocyte differentiation and induces insulin resistance in adipocytes. Biochem. Biophys. Res. Commun 2009, 338, 146–149.
[25]  Han, C.; Wang, J.; Li, L.; Zhang, Z.; Wang, L.; Pan, Z. The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J. Exp. Biol 2009, 212, 1553–1558.
[26]  Tuchinda, P.; Reutrakul, V.; Claeson, P. Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry 2002, 59, 169–173.


comments powered by Disqus